Just listened to the Paul Rennie and Alan Koehler interview and PR stated there is no cost to the patient. Is this just for the 600 under official review. How does this relate to our charge of $1,600, is this for patients outside the official company programme. PR didn’t make this clear.
Anyone the full bottle on this?
Everything else correlated what we discuss here about the remarkable reduction in pain and also the slowing and in many cases the stopping of cartilage degeneration.
- Forums
- ASX - By Stock
- PAR
- What a pain
What a pain, page-28
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $101.4M |
Open | High | Low | Value | Volume |
29.0¢ | 29.3¢ | 28.0¢ | $57.32K | 198.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12454 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 4443 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12454 | 0.285 |
5 | 148571 | 0.280 |
3 | 98402 | 0.275 |
6 | 72999 | 0.270 |
4 | 21233 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 4443 | 1 |
0.295 | 204237 | 3 |
0.300 | 203651 | 5 |
0.305 | 2600 | 1 |
0.310 | 36326 | 3 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |